Biomica

Biomica

Verified
Develops microbiome-based therapeutics to treat immune-mediated and infectious diseases.

Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$40—60m (Dealroom.co estimates Dec 2022.)
Rehovot Center District (HQ)
  • Edit
Get premium to view all results
DateInvestorsAmountRound
investor

$0.0

round
*

$10.0m

-
Total Funding000k

Recent News about Biomica

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo